Now live: Innocentive Marketplace. Get shortlisted for funded opportunities today.

Identification of an Early Lead Compound for the Treatment of Dengue

14 Submissions
Challenge closed

Challenge overview

The Seeker, 60°Pharmaceuticals, is looking for collaboration partners for identification of an early lead compound for the treatment of dengue. 

This is an electronic Request-for-Partners (eRFP) Challenge; the Solver will only need to submit a written proposal to be evaluated by the Seeker with a goal of establishing a collaborative partnership.

The Seeker, 60<sup>o </sup>Pharmaceuticals, is looking for collaboration partner(s) for identification of an early lead compound for the treatment of dengue. 

This is an electronic Request-for-Partners (eRFP) Challenge.  The Solver will write a preliminary proposal (about 5 pages including contact information) to be evaluated by the Seeker with a goal of establishing a collaborative partnership.  Upon completion of the evaluation, the Seeker may contact selected Solvers directly to discuss terms for further collaboration. 

The Seeker will provide incentives to selected Solvers for identification of an early lead compound, and reimburse reasonable costs. The monetary value of incentives and reasonable costs will vary depending on the number of selected Solvers selected and the scope of proposed work. 

(NOTE: only proposals from Solvers who have the ability to work as the collaboration partner will be considered.)

Use the slider to explore how the Challenge process works:

Register

Review & Accept

Submit

Win

To start solving this Challenge, log in to the Challenge Center or register as a Solver